Key Points
New Delhi, February 2. AIIMS, New Delhi, in collaboration with the Centre for Development of Advanced Computing (CDAC), Pune, has recently launched an AI platform, iOncology.ai, for facilitating early detection of Cancer, the official statement released said.. Cancer is globally estimated to be the most fatal disease than those from cardiovascular (Lancet, 2019) in high-income countries (HICs), and middle-income countries (MICs)...
According to the official statement released by AIIMS Delhi, at the core of this platform lies a sophisticated AI system capable of analyzing complex medical data, including diagnosis, with unprecedented accuracy and efficiency. platform encapsulates deep learning models...
As breast and ovarian cancers are reported to be the most common cause of cancer amongst women in India, the first application of the iOncology.ai platform has been done by AIIMS in these two domains...
Earlier, the Department of Rheumatology, AIIMS New Delhi signs a Memorandum of Understanding (MoU) with DGE Minister of Labour & Employment, Govt of India on Thursday at 3.15 pm in Shram Shakti Bhawan, New Delhi...
According to the official statement by AIIMS, the MoU with DGE is anticipated to bring a ray of hope to patients with disabilities arising due to rheumatological disorders by addressing various aspects of their challenges...
